Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

被引：126

作者：

Lyke, Kirsten E. ^{[1
]}

Atmar, Robert L. ^{[2
]}

Islas, Clara Dominguez ^{[3
]}

Posavad, Christine M. ^{[3
,4
]}

Szydlo, Daniel ^{[5
]}

Chourdhury, Rahul Paul ^{[5
]}

Deming, Meagan E. ^{[1
]}

Eaton, Amanda ^{[6
]}

Jackson, Lisa A. ^{[7
]}

Branche, Angela R. ^{[8
]}

Sahly, Hana M. El ^{[2
]}

Rostad, Christina A. ^{[9
]}

Martin, Judith M. ^{[10
]}

Johnston, Christine ^{[3
,4
,11
]}

Rupp, Richard E. ^{[12
]}

Mulligan, Mark J. ^{[13
]}

Brady, Rebecca C. ^{[14
]}

Frenck, Robert W., Jr. ^{[14
]}

Backer, Martin ^{[15
]}

Kottkamp, Angelica C. ^{[13
]}

Babu, Tara M. ^{[11
]}

Rajakumar, Kumaravel ^{[10
]}

Edupuganti, Srilatha ^{[16
,17
]}

Dobrzynski, David ^{[8
]}

Coler, Rhea N. ^{[18
,19
]}

Archer, Janet I. ^{[20
]}

Crandon, Sonja ^{[21
]}

Zemanek, Jillian A. ^{[5
]}

Brown, Elizabeth R. ^{[3
]}

Neuzil, Kathleen M. ^{[1
]}

Stephens, David S. ^{[16
]}

Post, Diane J. ^{[21
]}

Nayak, Seema U. ^{[21
]}

Suthar, Mehul S. ^{[22
]}

Roberts, Paul C. ^{[21
]}

Beigel, John H. ^{[21
]}

Montefiori, David C. ^{[23
]}

DMID Std Grp

机构：

[1] Univ Maryland Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA

[2] Baylor Coll Med, Dept Med & Mol Virol & Microbiol, Houston, TX 77030 USA

[3] Univ Washington, Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA USA

[4] Univ Washington, Fred Hutchinson Canc Res Ctr, Dept Lab Med & Pathol, Seattle, WA USA

[5] Univ Washington, Stat Ctr HIV AIDS Res & Prevent SCHARP, Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[6] Duke Univ Med Ctr, Dept Surg, Durham, NC USA

[7] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA

[8] Univ Rochester, Dept Med, Div Infect Dis, Rochester, NY USA

[9] Emory Univ Sch Med & Childrens Healthcare Atlanta, Ctr Childhood Infect & Vaccines, Dept Pediat, Atlanta, GA USA

[10] Univ Pittsburgh Sch Med, Dept Pediat, Pittsburgh, PA USA

[11] Univ Washington, Dept Med, Seattle, WA USA

[12] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX USA

[13] NYU Langone Vaccine Ctr, NYU Grossman Sch Med, Dept Med, Div Infect Dis & Immunol, New York, NY USA

[14] Univ Cincinnati Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH USA

[15] NYU Langone Hosp, Mineola, NY USA

[16] Emory Univ Sch Med, Dept Med, Atlanta, GA USA

[17] Hope Clin Emory Vaccine Ctr, Atlanta, GA USA

[18] Univ Washington Sch Med, Seattle Childrens Res Inst, Seattle, WA USA

[19] Univ Washington Sch Med, Dept Pediat, Seattle, WA USA

[20] FHI360, Durham, NC 27701 USA

[21] Natl Inst Allergy & Infect Dis, NIH, Div Microbiol & Infect Dis, Bethesda, MD USA

[22] Emory Univ, Atlanta, GA USA

[23] Duke Univ Med Ctr, Duke Human Vaccine Inst, Durham, NC 27710 USA

来源：

CELL REPORTS MEDICINE | 2022年 / 3卷 / 07期

基金：

美国国家卫生研究院;

关键词：

BA.2.12.1; BA.4/BA.5; booster; COVID-19; mRNA vaccine; neutralizing antibody; Omicron variant; recombinant adenovirus vaccine; SARS-CoV-2; sublineage;

D O I：

10.1016/j.xcrm.2022.100679

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibits reduced susceptibility to vaccine-induced neutralizing antibodies, requiring a boost to generate protective immunity. We assess the magnitude and short-term durability of neutralizing antibodies after homologous and heterologous boosting with mRNA and Ad26.COV2.S vaccines. All prime-boost combinations substantially increase the neutralization titers to Omicron, although the boosted titers decline rapidly within 2 months from the peak response compared with boosted titers against the prototypic D614G variant. Boosted Omicron neutralization titers are substantially higher for homologous mRNA vaccine boosting, and for heterologous mRNA and Ad26.COV2.S vaccine boosting, compared with homologous Ad26.COV2.S boosting. Homologous mRNA vaccine boosting generates nearly equivalent neutralizing activity against Omicron sublineages BA.1, BA.2, and BA.3 but modestly reduced neutralizing activity against BA.2.12.1 and BA.4/BA.5 compared with BA.1. These results have implications for boosting requirements to protect against Omicron and future variants of SARS-CoV-2.

引用

页数：13

共 50 条

[1] Therapeutic Potential of Neutralizing Monoclonal Antibodies (nMAbs) against SARS-CoV-2 Omicron Variant
Parua, Pijus
Ghosh, Somnath
Jana, Koushik
Seth, Arnab
Debnath, Biplab
Rout, Saroj Kumar
Sarangi, Manoj Kumar
Dash, Rasmita
Halder, Jitu
Rajwar, Tushar Kanti
Pradhan, Deepak
Rai, Vineet Kumar
Dash, Priyanka
Das, Chandan
Kar, Biswakanth
Ghosh, Goutam
Rath, Goutam
CURRENT PHARMACEUTICAL DESIGN, 2025, 31 (10) : 753 - 773
[2] Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
Na-Na Zhang
Rong-Rong Zhang
Yi-Fei Zhang
Kai Ji
Xiao-Chuan Xiong
Qian-Shan Qin
Peng Gao
Xi-Shan Lu
Hang-Yu Zhou
Hai-Feng Song
Bo Ying
Cheng-Feng Qin
Cell Research, 2022, 32 : 401 - 403
[3] Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
Zhang, Na-Na
Zhang, Rong-Rong
Zhang, Yi-Fei
Ji, Kai
Xiong, Xiao-Chuan
Qin, Qian-Shan
Gao, Peng
Lu, Xi-Shan
Zhou, Hang-Yu
Song, Hai-Feng
Ying, Bo
Qin, Cheng-Feng
CELL RESEARCH, 2022, 32 (04) : 401 - 403
[4] Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine-boosted nonhuman primates
Corbett, Kizzmekia S.
Gagne, Matthew
Wagner, Danielle A.
O' Connell, Sarah
Narpala, Sandeep R.
Flebbe, Dillon R.
Andrew, Shayne F.
Davis, Rachel L.
Flynn, Barbara
Johnston, Timothy S.
Stringham, Christopher D.
Lai, Lilin
Valentin, Daniel
Van Ry, Alex
Flinchbaugh, Zackery
Werner, Anne P.
Moliva, Juan, I
Sriparna, Manjari
O'Dell, Sijy
Schmidt, Stephen D.
Tucker, Courtney
Choi, Angela
Koch, Matthew
Bock, Kevin W.
Minai, Mahnaz
Nagata, Bianca M.
Alvarado, Gabriela S.
Henry, Amy R.
Laboune, Farida
Schramm, Chaim A.
Zhang, Yi
Yang, Eun Sung
Wang, Lingshu
Choe, Misook
Boyoglu-Barnum, Seyhan
Wei, Shi
Lamb, Evan
Nurmukhambetova, Saule T.
Provost, Samantha J.
Donaldson, Mitzi M.
Marquez, Josue
Todd, John-Paul M.
Cook, Anthony
Dodson, Alan
Pekosz, Andrew
Boritz, Eli
Ploquin, Aurelie
Doria-Rose, Nicole
Pessaint, Laurent
Andersen, Hanne
SCIENCE, 2021, 374 (6573) : 1343 - +
[5] Major classes of neutralizing antibodies evaded by the SARS-CoV-2 Omicron variant
Yuan, Meng
Wilson, Ian A.
STRUCTURE, 2023, 31 (07) : 755 - 757
[6] Vaccine protection against the SARS-CoV-2 Omicron variant in macaques
Chandrashekar, Abishek
Yu, Jingyou
McMahan, Katherine
Jacob-Dolan, Catherine
Liu, Jinyan
He, Xuan
Hope, David
Anioke, Tochi
Barrett, Julia
Chung, Benjamin
Hachmann, Nicole P.
Lifton, Michelle
Miller, Jessica
Powers, Olivia
Sciacca, Michaela
Sellers, Daniel
Siamatu, Mazuba
Surve, Nehalee
VanWyk, Haley
Wan, Huahua
Wu, Cindy
Pessaint, Laurent
Valentin, Daniel
Van Ry, Alex
Muench, Jeanne
Boursiquot, Mona
Cook, Anthony
Velasco, Jason
Teow, Elyse
Boon, Adrianus C. M.
Suthar, Mehul S.
Jain, Neharika
Martinot, Amanda J.
Lewis, Mark G.
Andersen, Hanne
Barouch, Dan H.
CELL, 2022, 185 (09) : 1549 - +
[7] Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Chiang, Hsiao-Ling
Liang, Kang-Hao
Lu, Ruei-Min
Kuo, Ting-Wen
Lin, Yi-Ling
Wu, Han-Chung
JOURNAL OF BIOMEDICAL SCIENCE, 2023, 30 (01)
[8] Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Hsiao-Ling Chiang
Kang-Hao Liang
Ruei-Min Lu
Ting-Wen Kuo
Yi‑Ling Lin
Han-Chung Wu
Journal of Biomedical Science, 30
[9] Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
Stéphane Marot
Isabelle Malet
Valentin Leducq
Karen Zafilaza
Delphine Sterlin
Delphine Planas
Adélie Gothland
Aude Jary
Karim Dorgham
Timothée Bruel
Sonia Burrel
David Boutolleau
Olivier Schwartz
Guy Gorochov
Vincent Calvez
Anne-Geneviève Marcelin
Nature Communications, 12
[10] Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster
da Silva, Almir Ribeiro, Jr.
Villas-Boas, Lucy Santos
de Paula, Anderson Vicente
Tozetto-Mendoza, Tania Regina
Honorato, Layla
Witkin, Steven S.
Mendes-Correa, Maria Cassia
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2022, 64

← 1 2 3 4 5 →